These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 331549)

  • 1. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
    Trabant R; Poljakovic Z; Trabant D
    Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)].
    Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H
    Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907
    [No Abstract]   [Full Text] [Related]  

  • 3. [1st experiences with Piracetam as a noothropic substance in organic psychoses].
    Suchenwirth R
    Med Monatsschr; 1973 Oct; 27(10):467-9. PubMed ID: 4591359
    [No Abstract]   [Full Text] [Related]  

  • 4. DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
    Misurec J; Morávek Z; Náhunek K; Cesková E; Sláma B; Svestka J
    Act Nerv Super (Praha); 1978 Dec; 20(4):266-7. PubMed ID: 367038
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience using nootropil in patients with chronic ischemic heart disease].
    Shubina TI; Zaĭtsev VP
    Klin Med (Mosk); 1989 May; 67(5):36-8. PubMed ID: 2671485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Certain principles for differential utilization of metabolic treatment preparations in the complex therapy of mental disorders].
    Avrutskiĭ GIa; Laskova NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1077-83. PubMed ID: 484144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of Kalicor in the treatment of psycho-organic syndrome].
    Jovicić A; Miljanović B; Preradović M; Nikić S
    Vojnosanit Pregl; 1979; 36(4):284-6. PubMed ID: 506152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nonpsychotic involutional inhibited depressions and psycho-organic deteriorations: treatment with Viloxazine and piracetam].
    Borromei A; Caramelli R; Conti M; Giancola LC; Guerra L
    Minerva Med; 1989 May; 80(5):475-82. PubMed ID: 2747975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
    Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
    J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of piracetam treatment of acute viral neuroinfections].
    Niss AI; Umanskiĭ KG; Maksutova EL; Rudometov IuP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):189-95. PubMed ID: 3984605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
    Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
    Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Piracetam in the treatment of alcohol-induced delirium].
    Snel H; Lehmann E; Velikonja M
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):947-9. PubMed ID: 6417503
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled clinical trial on the effect of piracetam in epileptic children.
    Kunneke PS; Malan GM
    Br J Clin Pract; 1979 Sep; 33(9):266-71. PubMed ID: 385029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of neuroleptic side-effects with piracetam (author's transl)].
    Sikora J; Kabes J; Pisvejc J
    Cesk Psychiatr; 1981 Apr; 77(2):137-42. PubMed ID: 6114800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.